Home | Community | Get Involved | Donate | | Site Index | Search Go Button
The mark, American Cancer Society, is a registered trademark of the American Cancer Society, Inc., and may not be copied, reproduced, transmitted, displayed, performed, distributed, sublicensed, altered, stored for subsequent use or otherwise used in whole or in part in any manner without ACS's prior written consent.
 
My Planner Register | Sign In Sign In


Making Treatment Decisions
 
    Types of Treatment
    Clinical Trials
    Treatment Decision Tools
    Choosing Treatment Facilities and Health Professionals
    Find Treatment Centers
    Nutrition for Cancer Patients
    Staying Active During Treatment
    Complementary & Alternative Therapies
    Guide to Cancer Drugs
    Talking About Cancer
    Message Boards
Glossary
    I Want to Help
  You can help in the fight against cancer. Donate and volunteer.
  Learn more
   
References

AABB. Misconceptions about TRALI risk reduction recommendations: Female plasma usage. Accessed at: www.aabb.org/Content/News_and_Media/Latest_News/lntrali012907.htm on June 18, 2009.

American Red Cross. Blood Eligibility Guidelines. Accessed at: http://www.redcross.org/en/eligibility#med on June 18, 2009.

American Red Cross. Practice Guidelines for blood transfusion: A compilation from recent peer-reviewed literature. Updated April 2007. Accessed at: http://www.redcross.org/www-files/Documents/WorkingWiththeRedCross/practiceguidelinesforbloodtrans.pdf on June 18, 2009.

American Red Cross, Southern Region. How blood is tested. Accessed at: http://web.redcrossblood.org/portal/GA/rc/bloodfacts/how_blood_tested.asp June 18, 2009.

Centers for Disease Control and Prevention. Fatal bacterial infections associated with platelet transfusions -- United States, 2004. MMWR.2005;54:168-170.

Demetri GD, Anderson KC. Disorders of blood cell production in clinical oncology. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical Oncology. 2nd ed. Philadelphia, PA: Churchill Livingstone; 2000: 642.

Dodd RY, Notari EP 4th, Stramer SL for the Transmissible Diseases Department, American Red Cross. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002 Aug;42(8):975-979.

Eder A. Blood Donors with a history of cancer. In: Eder A, Bianco C (Eds) Screening Blood Donors: Science, Reason, and the Blood Donation Questionnaire. 2007: AABB Press, Bethesda MD, 77-92.

Edgren G, Hjalgrim H, Reilly M, et al. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet. 2007; 369:1724–1730.

Food and Drug Administration, Blood Products Advisory Committee meeting transcripts, 1999-2008. Accessed at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm on June 18, 2009.

Hay SN, Scanga L, Brecher ME. Life, death, and the risk of transfusion: a university hospital experience. Transfusion. 2006 Sep;46(9):1491-3.

Henkel-Honke T, Oleck M. Artificial oxygen carriers: a current review. AANA J. 2007;75:205-211.

Higgins MJ, Blackall DP. Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion. Curr Hematol Rep. 2005;4:470-476.

Hjalgrim H, Edgren G, Rostgaard K, et al. Cancer Incidence in Blood Transfusion Recipients. J Natl Cancer Inst. 2007;99: 1864 – 1874.

Kauffman HM, McBride MA, Delmonici FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation. 2000;70:1747-1751.

Marik PE. The hazards of blood transfusion. British Journal of Hospital Medicine. 2009;70(1):12-15.

Marik PE, Corwin HL. Acute lung injury following blood transfusion: expanding the definition. Crit Care Med. 2008 Nov;36(11):3080-4.

Morris-Stiff G, Steel A, Savage P, et al. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant. 2004;4:444-446.

Ness PM, Rothko K. Principles of red blood cell transfusion. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, et al, eds. Hematology: Basic Principles and Practice. 3rd ed. Philadelphia, PA: Churchill Livingstone; 2000: 2241-2248.

Silliman CC. Transfusion-related acute lung injury (TRALI), in Hematology 2004, American Society of Hematology; 2004: 461-466. Accessed at: www.asheducationbook.org on June 19, 2009.

Triulzi DJ. Transfusion-related acute lung injury: an update. Hematology Am Soc Hematol Educ Program. 2006:497-501.

United Network for Organ Sharing (UNOS). Home page. Accessed at: www.unos.org/ on June 19, 2009.

United Network for Organ Sharing (UNOS). Questions and Answers. Accessed at: www.unos.org/qa.asp on June 18, 2009.

Vandegriff KD, Winslow RM. Hemospan: design principles for a new class of oxygen therapeutic. Artif Organs. 2009 Feb;33(2):133-8.

Zou S, Stramer SL, Notari EP, Kuhns MC, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion. 2009 Apr 28.

Last Medical Review: 07/13/2009
Last Revised: 07/13/2009

Printer-Friendly Page
Email this Page
Related Tools & Topics
Learn About Cancer  
Treatment Topics and Resources  
Building a Support Network  
Circle Of Sharing: Personalize Your Cancer Information  
Not registered yet?
  Register now or see reasons to register.  
Help |  About ACS |  Employment & Volunteer Opportunities |  Legal & Privacy Information |  Press Room
Copyright 2009 © American Cancer Society, Inc.
All content and works posted on this website are owned and
copyrighted by the American Cancer Society, Inc. All rights reserved.